A Case of Atopic Dermatitis with Alopecia Universalis in a Patient Treated with Abrocitinib
February 2022
in “
JAAD case reports
”
Studysummary This case report observed hair regrowth following the treatment of alopecia universalis and atopic dermatitis with tofacitinib, a JAK inhibitor.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jaadcasereports.org →